7.40

6.32% 0.44

After Hours: 7.47 0.07 +0.95%

Ginkgo Bioworks Holdings Inc (DNA)

Overview News Price History Option Chain Why DNA Down? Discussions Forecast

Ginkgo Bioworks Holdings Inc stock is traded at $7.40, with a volume of 1.43M. It is up +6.32% in the last 24 hours and down -6.21% over the past month. Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Previous Close:

$6.96

Open:

$7.09

24h Volume:

1.43M

Relative Volume:

1.23

Market Cap:

$498.32M

Revenue:

$141.31M

Net Income/Loss:

$-297.87M

P/E Ratio:

-1.3721

EPS:

-5.3933

Net Cash Flow:

$-168.20M

1W Performance:

+8.98%

1M Performance:

-6.21%

6M Performance:

-19.74%

1Y Performance:

-37.07%

1-Day Range:

$6.82

$7.42

1-Week Range:

$6.47

$7.7485

52-Week Range:

$5.37

$17.58

Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile

Name

Ginkgo Bioworks Holdings Inc

Sector

Healthcare (1080)

Industry

Biotechnology (604)

Phone

(877) 442-5362

Address

27 DRYDOCK AVENUE, BOSTON

Employee

485

Twitter

Next Earnings Date

2026-08-06

Latest SEC Filings

DNA's Discussions on Twitter

Compare DNA vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DNA Ginkgo Bioworks Holdings Inc	7.40	468.69M	141.31M	-297.87M	-168.20M	-5.3933
VRTX Vertex Pharmaceuticals Inc	548.05	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	834.04	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,039.78	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.13	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	209.46	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-15-24	Downgrade	BTIG Research	Neutral → Sell
May-10-24	Downgrade	William Blair	Mkt Perform → Underperform
Nov-14-23	Downgrade	Raymond James	Outperform → Mkt Perform
Nov-09-23	Downgrade	BTIG Research	Buy → Neutral
Jun-02-23	Downgrade	Goldman	Neutral → Sell
May-11-23	Downgrade	William Blair	Outperform → Mkt Perform
Nov-29-22	Initiated	Berenberg	Buy
Oct-04-22	Initiated	Morgan Stanley	Equal-Weight
May-18-22	Downgrade	BofA Securities	Neutral → Underperform
Mar-02-22	Resumed	Cowen	Outperform
Feb-23-22	Initiated	Goldman	Neutral
Feb-01-22	Initiated	BofA Securities	Neutral
Jan-28-22	Initiated	BofA Securities	Buy
Jan-07-22	Initiated	BTIG Research	Buy
Nov-29-21	Initiated	Jefferies	Buy
Oct-13-21	Initiated	Raymond James	Outperform
Oct-12-21	Initiated	William Blair	Outperform
Sep-20-21	Initiated	HSBC Securities	Buy

View All

Ginkgo Bioworks Holdings Inc Stock (DNA) Latest News

Aug 19, 2026

How Ginkgo Bioworks Holdings Inc. Class A (DNA) Affects Rotational Strategy Timing - Stock Traders Daily

Aug 16, 2026

Aug 15, 2026

Ginkgo Bioworks (DNA) Slides 6.22% as Shares Approach Key SupportEntry Point Alerts - vinanet.vn

Aug 15, 2026

These Analysts Think Ginkgo Bioworks Holdings, Inc.'s (NYSE:DNA) Sales Are Under Threat - Moomoo

Aug 15, 2026

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Analysts Just Slashed This Year's Revenue Estimates By 22% - simplywall.st

Aug 15, 2026

Aug 14, 2026

Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (JANX) and Ginkgo Bioworks Holdings (DNA) - The Globe and Mail

Aug 14, 2026